Episode 427
Addressing Disparities in Women's Healthcare - Sabrina Johnson, CEO Daré Bioscience
Talking Biotech with Dr. Kevin Folta · Colabra
March 30, 202438m 20s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Despite being over half of the population women's health care lags behind other areas of drug development. The problem is caused by many facets, but is augmented by the fact that many of the conditions are not life threatening or are functions of aging. Sabrina Johnson, CEO of Daré Bioscience, discusses how the disparity exists, the pipeline of drugs that seek to mitigate female-specific conditions, and how smaller, leaner businesses can have significant impacts in this space.
Topics
women's healthcaresexual healthcontraceptionnew drugsunmet needs